近5年高被引文献
The 2022 hormone therapy position statement of The North American Menopause Society
article
Full Text
OpenAlex
475
FWCI98.097
Management of osteoporosis in postmenopausal women: the 2021 position statement of The North American Menopause Society
article
Full Text
OpenAlex
331
FWCI49.563
ESR1 mutation as an emerging clinical biomarker in metastatic hormone receptor-positive breast cancer
review
Full Text
OpenAlex
254
FWCI9.15
Antibody–drug conjugates: Recent advances in linker chemistry
review
Full Text
OpenAlex
226
FWCI6.755
Evidence-based approaches for the management of side-effects of adjuvant endocrine therapy in patients with breast cancer
review
Full Text
OpenAlex
211
FWCI6.392
Current Perspectives on the Beneficial Effects of Soybean Isoflavones and Their Metabolites for Humans
review
Full Text
OpenAlex
209
FWCI9.017
Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials
review
Full Text
OpenAlex
203
FWCI11.181
The androgen receptor is a tumor suppressor in estrogen receptor–positive breast cancer
article
Full Text
OpenAlex
194
FWCI29.517
Recent development on COX-2 inhibitors as promising anti-inflammatory agents: The past 10 years
review
Full Text
OpenAlex
193
FWCI10.49
Menopause transition: Physiology and symptoms
review
Full Text
OpenAlex
185
FWCI9.597